Elzonris
- Product NDC
- 72187-0401
- 11-digit product format
- 721870401
- Labeler code
- 72187
- Product ID
- 72187-0401_f219a6c1-2e94-40a7-8b66-28520f7bb7f7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tagraxofusp
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Stemline Therapeutics, Inc.
- Application
- BLA761116
- Marketing category
- BLA
- Marketing start
- 2019-01-18
- Substance
- TAGRAXOFUSP
- Active strength
- 1000 ug/mL
- Pharmacologic classes
- CD123 Interaction [EPC], CD123 Interactions [MoA], Cytotoxin [EPC], Cytotoxins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Elzonris
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TAGRAXOFUSP | 1000 ug/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 8ZHS5657EH |
| Rxcui | 2109059, 2109064 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72187-0401-1 | Elzonris | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 11 |
| 72187-0401-1 | Elzonris | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 1 | | 11 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72187-0401 | ELZONRIS (TAGRAXOFUSP) INJECTION, SOLUTION [STEMLINE THERAPEUTICS, INC.] | 11 | Current NDC, Legacy NDC, 2 package rows | 20241212_80eb1080-fe20-4af0-b2a5-a67999923fa8.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72187-0401-1 | 72187040101 | 1 VIAL, SINGLE-DOSE in 1 CARTON (72187-0401-1) / 1 mL in 1 VIAL, SINGLE-DOSE | 2019-01-18 | 0000-00-00 | No | No | Current |